Advertisement
BIOX vs IPI
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BIOX is a Hold and IPI is a StrongBuy.
BIOX in downward trend: 10-day moving average moved below 50-day moving average on September 24, 2026
The 10-day moving average for BIOX crossed bearishly below the 50-day moving average on September 24, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 12 of 13 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 90%.
Technical Analysis (Indicators)
Bearish Trend Analysis
BIOX moved below its 50-day moving average on September 24, 2026 date and that indicates a change from an upward trend to a downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where BIOX declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 87%.
The Aroon Indicator for BIOX entered a downward trend on October 22, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Bullish Trend Analysis
The RSI Indicator shows that the ticker has stayed in the oversold zone for 7 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an Uptrend is expected.
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 10 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
Following a +0.85% 3-day Advance, the price is estimated to grow further. Considering data from situations where BIOX advanced for three days, in 181 of 237 cases, the price rose further within the following month. The odds of a continued upward trend are 76%.
BIOX may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is 18 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 56 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.246) is normal, around the industry mean (-0.286). P/E Ratio (-0.293) is within average values for comparable stocks, (8.446). Projected Growth (PEG Ratio) (1.236) is also within normal values, averaging (0.867). Dividend Yield (0.000) settles around the average of (0.127) among similar stocks. BIOX's P/S Ratio (0.103) is slightly lower than the industry average of (1.476).
The Tickeron Seasonality Score of 75 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Price Growth Rating for this company is 91 (best 1 - 100 worst), indicating slightly worse than average price growth. BIOX’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 95 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. BIOX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 77, placing this stock worse than average.
IPI's RSI Indicator is staying in oversold zone for 1 day
It is expected that a price bounce should occur soon.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 1 day, which means it's wise to expect a price bounce in the near future.
Following a +1.89% 3-day Advance, the price is estimated to grow further. Considering data from situations where IPI advanced for three days, in 207 of 269 cases, the price rose further within the following month. The odds of a continued upward trend are 77%.
IPI may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Bearish Trend Analysis
The Momentum Indicator moved below the 0 level on October 14, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on IPI as a result. In 74 of 93 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 80%.
The Moving Average Convergence Divergence Histogram (MACD) for IPI turned negative on October 22, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 43 similar instances when the indicator turned negative. In 31 of the 43 cases the stock turned lower in the days that followed. This puts the odds of success at 72%.
IPI moved below its 50-day moving average on September 23, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for IPI crossed bearishly below the 50-day moving average on September 28, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 13 of 17 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 76%.
The 50-day moving average for IPI moved below the 200-day moving average on October 16, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where IPI declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 76%.
The Aroon Indicator for IPI entered a downward trend on October 22, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron Valuation Rating of 3 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.804) is normal, around the industry mean (-0.286). P/E Ratio (15.462) is within average values for comparable stocks, (8.446). Projected Growth (PEG Ratio) (0.220) is also within normal values, averaging (0.867). IPI's Dividend Yield (0.975) is considerably higher than the industry average of (0.127). P/S Ratio (1.676) is also within normal values, averaging (1.476).
The Tickeron Price Growth Rating for this company is 62 (best 1 - 100 worst), indicating steady price growth. IPI’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 82 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is 94 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. IPI’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 77, placing this stock worse than average.
BIOX | IPI | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 68 | 67 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 56 Fair valued | 3 Undervalued | |
PROFIT vs RISK RATING 1..100 | 100 | 100 | |
SMR RATING 1..100 | 95 | 82 | |
PRICE GROWTH RATING 1..100 | 91 | 62 | |
P/E GROWTH RATING 1..100 | 18 | 94 | |
SEASONALITY SCORE 1..100 | 75 | n/a |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
IPI's Valuation (3) in the Other Metals Or Minerals industry is somewhat better than the same rating for BIOX (56) in the Financial Conglomerates industry. This means that IPI’s stock grew somewhat faster than BIOX’s over the last 12 months.
IPI's Profit vs Risk Rating (100) in the Other Metals Or Minerals industry is in the same range as BIOX (100) in the Financial Conglomerates industry. This means that IPI’s stock grew similarly to BIOX’s over the last 12 months.
IPI's SMR Rating (82) in the Other Metals Or Minerals industry is in the same range as BIOX (95) in the Financial Conglomerates industry. This means that IPI’s stock grew similarly to BIOX’s over the last 12 months.
IPI's Price Growth Rating (62) in the Other Metals Or Minerals industry is in the same range as BIOX (91) in the Financial Conglomerates industry. This means that IPI’s stock grew similarly to BIOX’s over the last 12 months.
BIOX's P/E Growth Rating (18) in the Financial Conglomerates industry is significantly better than the same rating for IPI (94) in the Other Metals Or Minerals industry. This means that BIOX’s stock grew significantly faster than IPI’s over the last 12 months.
| BIOX | IPI | |
|---|---|---|
| RSI ODDS (%) | 1 day ago 81% | 1 day ago 90% |
| Stochastic ODDS (%) | 1 day ago 69% | 1 day ago 77% |
| Momentum ODDS (%) | N/A | 1 day ago 80% |
| MACD ODDS (%) | N/A | 1 day ago 72% |
| TrendWeek ODDS (%) | 1 day ago 86% | 1 day ago 79% |
| TrendMonth ODDS (%) | 1 day ago 87% | 1 day ago 78% |
| Advances ODDS (%) | 11 days ago 76% | 7 days ago 77% |
| Declines ODDS (%) | 2 days ago 87% | 1 day ago 76% |
| BollingerBands ODDS (%) | 1 day ago 82% | 1 day ago 78% |
| Aroon ODDS (%) | 1 day ago 87% | 1 day ago 77% |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
BIOX’s FA Score shows that 1 FA rating(s) are green while IPI’s FA Score has 1 green FA rating(s).
- BIOX’s FA Score: 1 green, 4 red.
- IPI’s FA Score: 1 green, 4 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
BIOX’s TA Score shows that 4 TA indicator(s) are bullish while IPI’s TA Score has 4 bullish TA indicator(s).
- BIOX’s TA Score: 4 bullish, 4 bearish.
- IPI’s TA Score: 4 bullish, 7 bearish.
Price Growth
BIOX (@Chemicals: Agricultural) experienced а -13.42% price change this week, while IPI (@Chemicals: Agricultural) price change was -4.65% for the same time period.
The average weekly price growth across all stocks in the @Chemicals: Agricultural industry was -4.57%. For the same industry, the average monthly price growth was -19.38%, and the average quarterly price growth was -17.70%.
Reported Earning Dates
BIOX is expected to report earnings on Nov 11, 2026.
IPI is expected to report earnings on Nov 03, 2026.
Industries' Descriptions
@Chemicals: Agricultural (-4.57% weekly)The agricultural chemicals sector includes companies that produce chemical products for the agricultural industry applications like crop protection, animal health, biotechnology and pharmaceutical-related products. Some of the largest agricultural chemicals producers include Nutrien Ltd., Corteva Inc., and FMC Corporation.
Advertisement
IPI and
Correlation & Price change
A.I.dvisor indicates that over the last year, IPI has been closely correlated with CF. These tickers have moved in lockstep 67% of the time. This A.I.-generated data suggests there is a high statistical probability that if IPI jumps, then CF could also see price increases.